Alzheimer Disease  >>  PRX-03140  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
PRX-03140 / Resilience
NCT00672945: A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil

Terminated
2
420
US
PRX-03140, Placebo
Epix Pharmaceuticals, Inc.
Alzheimer's Disease
01/10
 
NCT00693004: Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease

Terminated
2
236
US
PRX-03140, Donepezil, Placebo
Epix Pharmaceuticals, Inc.
Alzheimer's Disease
01/10
 

Download Options